APO RESEARCH · REPORT
Alvimopan
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Product & engineering
Understand the product.
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Selected research
Market Structure
Global Alvimopan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report provides an overview of the global Alvimopan market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Alvimopan and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Alvimopan sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alvimopan market size, projected growth trends, production technologies, key applications, and end-use industries.
Alvimopan Segment by Company
Merck
Teva Pharmaceutical Industries Ltd
MSN Life Sciences Private Ltd
Alvimopan Segment by Type
Pharmaceutical Grade
Others
Alvimopan Segment by Application
Pharmaceutical
Other
Alvimopan Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alvimopan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alvimopan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alvimopan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Alvimopan market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alvimopan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alvimopan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Alvimopan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Grade
- Others
Applications
- Pharmaceutical
- Other
Companies covered
- Merck
- Teva Pharmaceutical Industries Ltd
- MSN Life Sciences Private Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Alvimopan Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Alvimopan Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Alvimopan Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Alvimopan Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Alvimopan Market Dynamics
- 2.1 Alvimopan Industry Trends
- 2.2 Alvimopan Industry Drivers
- 2.3 Alvimopan Industry Opportunities and Challenges
- 2.4 Alvimopan Industry Restraints
3 Alvimopan Market by Manufacturers
- 3.1 Global Alvimopan Revenue by Manufacturers (2021-2026)
- 3.2 Global Alvimopan Sales by Manufacturers (2021-2026)
- 3.3 Global Alvimopan Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Alvimopan Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Alvimopan Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Alvimopan Manufacturers, Product Type & Application
- 3.7 Global Alvimopan Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Alvimopan Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Alvimopan Players Market Share by Revenue in 2025
- 3.8.3 2025 Alvimopan Tier 1, Tier 2, and Tier 3
4 Alvimopan Market by Type
- 4.1 Alvimopan Type Introduction
- 4.1.1 Pharmaceutical Grade
- 4.1.2 Others
- 4.2 Global Alvimopan Sales by Type
- 4.2.1 Global Alvimopan Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Alvimopan Sales by Type (2021-2032)
- 4.2.3 Global Alvimopan Sales Market Share by Type (2021-2032)
- 4.3 Global Alvimopan Revenue by Type
- 4.3.1 Global Alvimopan Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Alvimopan Revenue by Type (2021-2032)
- 4.3.3 Global Alvimopan Revenue Market Share by Type (2021-2032)
5 Alvimopan Market by Application
- 5.1 Alvimopan Application Introduction
- 5.1.1 Pharmaceutical
- 5.1.2 Other
- 5.2 Global Alvimopan Sales by Application
- 5.2.1 Global Alvimopan Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Alvimopan Sales by Application (2021-2032)
- 5.2.3 Global Alvimopan Sales Market Share by Application (2021-2032)
- 5.3 Global Alvimopan Revenue by Application
- 5.3.1 Global Alvimopan Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Alvimopan Revenue by Application (2021-2032)
- 5.3.3 Global Alvimopan Revenue Market Share by Application (2021-2032)
6 Global Alvimopan Sales by Region
- 6.1 Global Alvimopan Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Alvimopan Sales by Region (2021-2032)
- 6.2.1 Global Alvimopan Sales by Region (2021-2026)
- 6.2.2 Global Alvimopan Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Alvimopan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Alvimopan Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Alvimopan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Alvimopan Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Alvimopan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Alvimopan Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Alvimopan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Alvimopan Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Alvimopan Revenue by Region
- 7.1 Global Alvimopan Revenue by Region
- 7.1.1 Global Alvimopan Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Alvimopan Revenue by Region (2021-2026)
- 7.1.3 Global Alvimopan Revenue by Region (2027-2032)
- 7.1.4 Global Alvimopan Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Alvimopan Revenue (2021-2032)
- 7.2.2 North America Alvimopan Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Alvimopan Revenue (2021-2032)
- 7.3.2 Europe Alvimopan Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Alvimopan Revenue (2021-2032)
- 7.4.2 Asia-Pacific Alvimopan Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Alvimopan Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Alvimopan Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Company Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck Alvimopan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Merck Alvimopan Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Teva Pharmaceutical Industries Ltd
- 8.2.1 Teva Pharmaceutical Industries Ltd Company Information
- 8.2.2 Teva Pharmaceutical Industries Ltd Business Overview
- 8.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio
- 8.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
- 8.3 MSN Life Sciences Private Ltd
- 8.3.1 MSN Life Sciences Private Ltd Company Information
- 8.3.2 MSN Life Sciences Private Ltd Business Overview
- 8.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 MSN Life Sciences Private Ltd Alvimopan Product Portfolio
- 8.3.5 MSN Life Sciences Private Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Alvimopan Value Chain Analysis
- 9.1.1 Alvimopan Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Alvimopan Production Mode & Process
- 9.2 Alvimopan Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Alvimopan Distributors
- 9.2.3 Alvimopan Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst